Glomerulosclerosis, Focal Segmental Clinical Trials

8 clinical trials for Glomerulosclerosis, Focal Segmental across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Nephrotic Syndrome Study Network — RECRUITING
• Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome. — RECRUITING
• The FOrMe Registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Registry) — RECRUITING
• Phase 2a Study of VX-147 in Adults With APOL1-mediated Focal Segmental Glomerulosclerosis — COMPLETED · PHASE2
• A Study of TRPC5 Channel Inhibitor in Patients With Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change Disease — TERMINATED · PHASE2
• A Study to Understand the Genetics and Clinical Course of Focal Segmental Glomerulosclerosis (FSGS), Treatment-Resistant Minimal Change Disease (TR-MCD), and Diabetic Nephropathy (DN) — TERMINATED
• Podocyte Retinoids — COMPLETED · PHASE2
• A Phase II, Repeat Dose, Proof of Mechanism Study of Losmapimod to Reduce Proteinuria in Patients With Focal Segmental Glomerulosclerosis (FSGS) — COMPLETED · PHASE2

Refine this search